These findings prompt the idea that the diet-induced increases of ileal eCBome mediators may result in preferential binding to CB1 over CB2 or PPARγ, with subsequent increases of intestinal permeability, inflammation, insulin resistance, and other metabolic disturbances. The gene discussed is CNR1; the disease is Insulin resistance.